BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27935212)

  • 21. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection.
    Ragni MV; Belle SH
    J Infect Dis; 2001 Apr; 183(7):1112-5. PubMed ID: 11237838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
    HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation.
    Vitale A; Spolverato G; Burra P; De Feo TM; Belli L; Donato F; Baroni GS; Marianelli T; Picciotto A; Toniutto P; Bhoori S; Passigato N; Lucà MG; Russo FP; Cillo U; Fagiuoli S;
    Transpl Int; 2015 Sep; 28(9):1055-65. PubMed ID: 25865602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States.
    Perumpail RB; Wong RJ; Scandling JD; Ha le D; Todo T; Bonham CA; Saab S; Younossi ZM; Ahmed A
    Clin Transplant; 2015 Oct; 29(10):920-6. PubMed ID: 26205329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
    Gutiérrez-Moreno M; Bernal-Bellido C; Suárez-Artacho G; Alamo-Martínez JM; Marín-Gómez LM; Serrano-Díaz-Canedo J; Padillo-Ruiz FJ; Gómez-Bravo MA
    Transplant Proc; 2012 Sep; 44(7):2100-2. PubMed ID: 22974923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant.
    Shelton BA; Berdahl G; Sawinski D; Linas BP; Reese PP; Mustian MN; Reed RD; MacLennan PA; Locke JE
    Am J Transplant; 2019 Jun; 19(6):1806-1819. PubMed ID: 30589503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation in haemophilia.
    Wilde J; Teixeira P; Bramhall SR; Gunson B; Mutimer D; Mirza DF
    Br J Haematol; 2002 Jun; 117(4):952-6. PubMed ID: 12060136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor survival after liver retransplantation: is hepatitis C to blame?
    Watt KD; Lyden ER; McCashland TM
    Liver Transpl; 2003 Oct; 9(10):1019-24. PubMed ID: 14526394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous Deceased Donor Liver and Kidney Transplantation in a Human Immunodeficiency Virus/Hepatitis C Virus -Coinfected Patient With Hemophilia in Japan: A Case Report.
    Eguchi S; Hidaka M; Natsuda K; Hara T; Kugiyama T; Hamada T; Tanaka T; Ono S; Adachi T; Kanetaka K; Soyama A; Mochizuki Y; Sakai H
    Transplant Proc; 2020 Nov; 52(9):2786-2789. PubMed ID: 32522360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
    Pineda JA; García-García JA; Aguilar-Guisado M; Ríos-Villegas MJ; Ruiz-Morales J; Rivero A; del Valle J; Luque R; Rodríguez-Baño J; González-Serrano M; Camacho A; Macías J; Grilo I; Gómez-Mateos JM;
    Hepatology; 2007 Sep; 46(3):622-30. PubMed ID: 17659577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C at the israeli national hemophilia center.
    Maor Y; Bashari D; Kenet G; Lalezari S; Lubetsky A; Luboshitz J; Schapiro JM; Avidan B; Bar-Meir S; Martinowitz U
    Haemophilia; 2006 Jan; 12(1):68-74. PubMed ID: 16409178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
    Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
    Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.
    Locke JE; Mehta S; Reed RD; MacLennan P; Massie A; Nellore A; Durand C; Segev DL
    J Am Soc Nephrol; 2015 Sep; 26(9):2222-9. PubMed ID: 25791727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years.
    Quintana M; del Amo J; Barrasa A; Pérez-Hoyos S; Ferreros I; Hernández F; Villar A; Jiménez V; Bolúmar F
    Haemophilia; 2003 Sep; 9(5):605-12. PubMed ID: 14511302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.